US 12,201,613 B2
Biosensing platform for detecting viral infections and methods for screening a modulator of viral infections and protecting therefrom
Chia-Ching Chang, Hsinchu (TW); Dar-Bin Shieh, Hsinchu (TW); Chia-Yu Chang, Hsinchu (TW); Lik Voon Kiew, Hsinchu (TW); Choon-Han Heh, Hsinchu (TW); Bey-Fen Leo, Hsinchu (TW); and Lip-Yong Chung, Hsinchu (TW)
Assigned to PIN JYE BIO TECH CO., LTD., Taipei (TW)
Filed by PIN JYE BIO TECH CO., LTD., Taipei (TW)
Filed on Oct. 20, 2021, as Appl. No. 17/505,693.
Claims priority of provisional application 63/094,403, filed on Oct. 21, 2020.
Prior Publication US 2022/0117936 A1, Apr. 21, 2022
Int. Cl. G01N 27/02 (2006.01); A61K 31/401 (2006.01); A61K 31/404 (2006.01); G01N 27/327 (2006.01)
CPC A61K 31/404 (2013.01) [A61K 31/401 (2013.01); G01N 27/026 (2013.01); G01N 27/3272 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A method for screening a modulator of a viral infection, comprising:
providing a biosensing platform including:
an insulating support;
a working electrode formed from an electrically conductive layer deposited on a surface of the insulating support; and
angiotensin converting enzyme 2 (ACE2) or a fragment thereof coated on the working electrode;
pretreating the working electrode of the biosensing platform with a modulator candidate;
contacting the working electrode with a spike protein or a fragment thereof from a virus of interest in absence or presence of the modulator candidate; and
measuring a level of electrochemical impedance of the working electrode,
wherein a difference in the level of the electrochemical impedance of the working electrode pretreated with the modulator candidate compared to a reference level indicates the modulator candidate as the modulator capable of altering an interaction of the ACE2 and the spike protein or a variant thereof, thereby modulating the viral infection.